Who
Michael James Morrissey
EVP, Head of Tech. Operations
Company insider
Files Form 4 as: EVP, Head of Tech. Operations, Incyte.
In numbers
- Trades disclosed
- 47
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $7.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jan 2020
- Last trade
- 23 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 27 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —6,426 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —8,999 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —6,426 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —8,999 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $19K185 at $102.67 | filing |
| 2 Feb 2026filed 4 Feb 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $19K185 at $102.67 | filing |
| 20 Jan 2026filed 21 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $44K429 at $102.62 | filing |
| 20 Jan 2026filed 21 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $44K429 at $102.62 | filing |
| 16 Jan 2026filed 21 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —7,426 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —7,426 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $25K254 at $98.77 | filing |
| 31 Dec 2025filed 5 Jan 2026 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $25K254 at $98.77 | filing |
| 17 Dec 2025filed 18 Dec 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $420K4,323 at $97.26 | filing |
| 16 Dec 2025filed 18 Dec 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $81K833 at $97.42 | filing |
| 16 Dec 2025filed 18 Dec 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $5.2M53,175 at $97.29 | filing |
| 1 Dec 2025filed 3 Dec 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $33K326 at $102.04 | filing |
| 15 Jul 2025filed 17 Jul 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —10,961 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —4,649 at $0.00 | filing |
| 31 Jan 2025filed 3 Feb 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —10,552 at $0.00 | filing |
| 21 Jan 2025filed 22 Jan 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $32K429 at $73.47 | filing |
News
Comparing Madrigal Pharmaceuticals (NASDAQ:MDGL) and Incyte (NASDAQ:INCY)INCY · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Michael James Morrissey; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.